CYP1A1/20-HETE/GPR75轴介导的阿拉基酸代谢失调在H型高血压的发病因子
Hangyu Lv1, Lingyun Liu1, Baoling Bai1
1Beijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Children's Medical Center, Capital Medical University, Capital Institute of Pediatrics, Beijing 100020, China.
International journal of molecular sciences
|July 12, 2025
概括
在H型高血压模型中,高氨酸的饮食降低了氨酸 (AA). 叶酸使AA水平正常化并调节关键基因表达,这表明了一种新的治疗途径.
科学领域:
- 生物化学 生物化学
- 基因组学就是基因组学.
- 心血管研究研究心血管研究
背景情况:
- 对于H型高血压的发病因子,目前尚不完全了解.
- 阿拉基酸 (AA) 代谢对心血管健康起着重要作用.
- 饮食因素,如氨酸,可以影响高血压的发展.
研究的目的:
- 为了阐明H型高血压的致病机制.
- 调查阿拉基酸 (AA) 代谢在H型高血压中的作用.
- 探索叶酸在调节AA代谢中的治疗潜力.
主要方法:
- 通过高氨酸饮食建立了H型高血压的老鼠模型.
- 使用了非向血清代谢学,转录学,西式涂抹和RT-qPCR.
- 使用EA.hy926内皮细胞进行了体外研究,并分析了美国NHANES数据.
主要成果:
- 氨酸诱导的H型高血压模型显示血清阿拉基酸 (AA) 减少.
- 叶酸补充剂使AA水平正常化,并降低了AA通路基因 (Cyp1a1,Gpr75) 的调节.
- 甲因暴露上调了内皮细胞中的CYP1A1和GPR75信号;AA,LA,GLA与NHANES数据中的高血压患病率相关.
结论:
- 通过CYP1A1/20-HETE/GPR75轴介导的AA代谢失调与H型高血压有关.
- 叶酸在正常化AA代谢方面表现出潜力,并提供治疗见解.
- 这些发现表明,对于管理H型高血压来说,有新的治疗点.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
930
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
930
Hypertension II: Pathophysiology
88
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
88
Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
892
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
892
Adrenergic Receptors: ɑ Subtype
1.9K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.9K
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K


